Complication Rates of Central Venous vs Midline Catheters in Hospitalized Adults
Ultrasound Guided Central Venous Catheter
+ Ultrasound Guided Midline Catheter
Supportive Care Study
Summary
Study start date: February 1, 2026
Actual date on which the first participant was enrolled.This study aims to compare complication rates between two types of catheters used in hospitals: central venous catheters (CVCs) and midline catheters. Every year, millions of these catheters are used in the United States, and they can sometimes lead to infections or other issues like blood clots. While some alternatives like peripherally inserted central catheters (PICCs) have been tried, they also come with risks. Midline catheters, which don't extend as far into the body as CVCs or PICCs, have shown promise in reducing these complications. This research seeks to learn more about the safety and effectiveness of CVCs compared to midline catheters, as no large-scale studies have been conducted on this topic before. The trial will take place at a single urban academic center, involving adult patients who require certain medical support. These patients will be randomly assigned to receive either a CVC or a midline catheter. The study will last for a year, and the decision to participate will be made in the emergency department, where a clinician will discuss the trial with the patient. If the patient agrees, they will sign a consent form before the catheter is placed. The goal is to gather information on the rates of complications like infections or blood clots associated with each type of catheter, as well as any potential differences in patient outcomes.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.100 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Supportive Care Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.Over 18 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.2 intervention groups are designated in this study
This study does not include a placebo group
Treatment Groups
Group I
Active ComparatorGroup II
Active ComparatorStudy Objectives
Primary Objectives
Secondary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location